Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-19

FDA Approved: ZERBAXA — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved ZERBAXA (ceftolozane and tazobactam) via Original Application for the treatment of complicated intra-abdominal infections and complicated urinary t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zerbaxa (ceftolozane-tazobactam)

Snippet

ORIG AP for ZERBAXA (CEFTOLOZANE AND TAZOBACTAM)